Long Non-Coding RNA GABPB1-AS1 Augments Malignancy of Glioma Cells by Sequestering MicroRNA-330 and Reinforcing the ZNF367/Cell Cycle Signaling Pathway

References

• Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol. 2014;16(7):896–913. doi:10.1093/neuonc/nou08724842956
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-127157931
   PubMed Web of Science ®Google Scholar
• Tamtaji OR, Mirzaei H, Shamshirian A, Shamshirian D, Behnam M, Asemi Z. New trends in glioma cancer therapy: targeting Na(+)/H (+) exchangers. J Cell Physiol. 2020;235(2):658–665. doi:10.1002/jcp.2901431250444
   PubMed Web of Science ®Google Scholar
• Weller M, Cloughesy T, Perry JR, Wick W. Standards of care for treatment of recurrent glioblastoma–are we there yet? Neuro Oncol. 2013;15(1):4–27. doi:10.1093/neuonc/nos27323136223
   PubMed Web of Science ®Google Scholar
• Kumar AA, Abraham Koshy A. Regression of recurrent high-grade glioma with temozolomide, dexamethasone, and levetiracetam: case report and review of the literature. World Neurosurg. 2017;108(990):e911–990 e916. doi:10.1016/j.wneu.2017.08.136
   Web of Science ®Google Scholar
• Lorenzi L, Avila Cobos F, Decock A, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58(4):191–199. doi:10.1002/gcc.2270930461116
   PubMed Web of Science ®Google Scholar
• Dang Y, Wei X, Xue L, Wen F, Gu J, Zheng H. Long non-coding RNA in Glioma: target miRNA and signaling pathways. Clin Lab. 2018;64(6):887–894. doi:10.7754/Clin.Lab.2018.18010729945317
   PubMed Web of Science ®Google Scholar
• Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24(16):R762–776. doi:10.1016/j.cub.2014.06.04325137592
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132. doi:10.1016/j.canlet.2018.09.01930237038
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.01421802130
   PubMed Web of Science ®Google Scholar
• Smillie CL, Sirey T, Ponting CP. Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk. Crit Rev Biochem Mol Biol. 2018;53(3):231–245. doi:10.1080/10409238.2018.144754229569941
   PubMed Web of Science ®Google Scholar
• Wang C, Chen Y, Wang Y, et al. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J Exp Clin Cancer Res. 2019;38(1):371. doi:10.1186/s13046-019-1361-231438982
   PubMed Web of Science ®Google Scholar
• Zhong C, Yu Q, Peng Y, et al. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma. J Exp Clin Cancer Res. 2021;40(1):123. doi:10.1186/s13046-021-01928-433832517
   PubMed Web of Science ®Google Scholar
• Tani H, Onuma Y, Ito Y, Torimura M. Long non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cells. PLoS One. 2014;9(8):e106282. doi:10.1371/journal.pone.010628225171338
   PubMed Web of Science ®Google Scholar
• Cui L, Nai M, Zhang K, Li L, Li R. lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p. Cancer Manag Res. 2019;11:651–667. doi:10.2147/CMAR.S17652530666161
   PubMed Web of Science ®Google Scholar
• Xiong X, Shi Q, Yang X, Wang W, Tao J. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. J Cell Physiol. 2019;234(9):15619–15626. doi:10.1002/jcp.2820930712321
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Naghizadeh S, et al. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. J Cell Physiol. 2020;235(2):920–931. doi:10.1002/jcp.2900731241772
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Mansoori B, Duijf PHG, et al. Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration. J Cell Physiol. 2021;236(1):273–283. doi:10.1002/jcp.2984032583462
   PubMed Web of Science ®Google Scholar
• Asano H, Murate T, Naoe T, Saito H, Stamatoyannopoulos G. Molecular cloning and characterization of ZFF29: a protein containing a unique Cys2His2 zinc-finger motif. Biochem J. 2004;384(Pt 3):647–653. doi:10.1042/BJ2004039415344908
   PubMed Web of Science ®Google Scholar
• Aslan B, Monroig P, Hsu MC, et al. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015;6(1):7351. doi:10.1038/ncomms835126081979
   PubMed Web of Science ®Google Scholar
• Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23(1):53. doi:10.1186/s12929-016-0269-927411336
   PubMed Web of Science ®Google Scholar
• Yuan X, Dai M, Xu D. TERT promoter mutations and GABP transcription factors in carcinogenesis: more foes than friends. Cancer Lett. 2020;493:1–9. doi:10.1016/j.canlet.2020.07.00332768523
   PubMed Web of Science ®Google Scholar
• Seliger C, Luber C, Gerken M, et al. Use of metformin and survival of patients with high-grade glioma. Int J Cancer. 2019;144(2):273–280. doi:10.1002/ijc.3178330091464
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang J, Feng Y, Li Z, Jiang Y. Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer. Cancer Med. 2020;9(19):7279–7292. doi:10.1002/cam4.337533094914
   PubMed Web of Science ®Google Scholar
• Li J, Zhu Y, Wang H, Ji X. Targeting long noncoding RNA in Glioma: a pathway perspective. Mol Ther Nucleic Acids. 2018;13:431–441. doi:10.1016/j.omtn.2018.09.02330388617
   PubMedGoogle Scholar
• Xiao H, Ding N, Liao H, et al. Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients. Medicine (Baltimore). 2019;98(45):e17583. doi:10.1097/MD.000000000001758331702614
   PubMed Web of Science ®Google Scholar
• Zhao WH, Yuan HY, Ren XY, Huang K, Guo ZY. Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value. Adv Clin Exp Med. 2019;28(9):1179–1183. doi:10.17219/acem/9952731414734
   PubMed Web of Science ®Google Scholar
• Ou R, Lv M, Liu X, et al. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis. FASEB J. 2020;34(10):13211–13223. doi:10.1096/fj.202000762R32844486
   PubMed Web of Science ®Google Scholar
• Wu DM, Wang S, Wen X, et al. Long noncoding RNA nuclear enriched abundant transcript 1 impacts cell proliferation, invasion, and migration of glioma through regulating miR-139-5p/CDK6. J Cell Physiol. 2019;234(5):5972–5987. doi:10.1002/jcp.2709330515782
   PubMed Web of Science ®Google Scholar
• Huang Y, Sun H, Ma X, et al. HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression. Life Sci. 2020;254:117180. doi:10.1016/j.lfs.2019.11718031863778
   PubMed Web of Science ®Google Scholar
• Zhao H, Hu GM, Wang WL, Wang ZH, Fang Y, Liu YL. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression. Eur Rev Med Pharmacol Sci. 2019;23(17):7295–7306. doi:10.26355/eurrev_201909_1883431539116
   PubMed Web of Science ®Google Scholar
• Chen J, Chen T, Zhu Y, et al. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res. 2019;38(1):398. doi:10.1186/s13046-019-1376-831511040
   PubMed Web of Science ®Google Scholar
• Wang H, Liu G, Li T, Wang N, Wu J, Zhi H. MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1. Arch Med Sci. 2020;16(5):1166–1175. doi:10.5114/aoms.2020.9502732864006
   PubMed Web of Science ®Google Scholar
• Wu X, Zhang X, Yu L, et al. Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer. Oncogene. 2020;39(12):2568–2582. doi:10.1038/s41388-020-1166-y31988454
   PubMed Web of Science ®Google Scholar
• Zeng H, Li T, Zhai D, et al. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int J Biol Sci. 2020;16(12):2084–2093. doi:10.7150/ijbs.4420432549756
   PubMed Web of Science ®Google Scholar
• Shi H, Li H, Zhen T, Dong Y, Pei X, Zhang X. The potential therapeutic role of exosomal microRNA-520b derived from normal fibroblasts in pancreatic cancer. Mol Ther Nucleic Acids. 2020;20:373–384. doi:10.1016/j.omtn.2019.12.02932200272
   PubMedGoogle Scholar
• Ouyang Q, Xu L, Cui H, Xu M, Yi L. MicroRNAs and cell cycle of malignant glioma. Int J Neurosci. 2016;126(1):1–9. doi:10.3109/00207454.2015.101788126000816
   PubMed Web of Science ®Google Scholar
• Wang Z, Qu H, Gong W, Liu A. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. IUBMB Life. 2018;70(11):1164–1176. doi:10.1002/iub.193430281914
   PubMed Web of Science ®Google Scholar
• Feng L, Ma J, Ji H, Liu Y, Hu W. miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. Biosci Rep. 2017;37(3). doi:10.1042/BSR20170019
   Web of Science ®Google Scholar
• Naef V, Monticelli S, Corsinovi D, Mazzetto MT, Cellerino A, Ori M. The age-regulated zinc finger factor ZNF367 is a new modulator of neuroblast proliferation during embryonic neurogenesis. Sci Rep. 2018;8(1):11836. doi:10.1038/s41598-018-30302-230087422
   PubMed Web of Science ®Google Scholar